BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 16547278)

  • 1. Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3-/- mice with experimental autoimmune encephalomyelitis.
    Liu L; Huang D; Matsui M; He TT; Hu T; Demartino J; Lu B; Gerard C; Ransohoff RM
    J Immunol; 2006 Apr; 176(7):4399-409. PubMed ID: 16547278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis.
    Klein RS; Izikson L; Means T; Gibson HD; Lin E; Sobel RA; Weiner HL; Luster AD
    J Immunol; 2004 Jan; 172(1):550-9. PubMed ID: 14688366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE.
    Mony JT; Khorooshi R; Owens T
    Mult Scler; 2014 Sep; 20(10):1312-21. PubMed ID: 24552747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis.
    Huang DR; Wang J; Kivisakk P; Rollins BJ; Ransohoff RM
    J Exp Med; 2001 Mar; 193(6):713-26. PubMed ID: 11257138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periplocoside E inhibits experimental allergic encephalomyelitis by suppressing interleukin 12-dependent CCR5 expression and interferon-gamma-dependent CXCR3 expression in T lymphocytes.
    Zhu YN; Zhong XG; Feng JQ; Yang YF; Fu YF; Ni J; Liu QF; Tang W; Zhao WM; Zuo JP
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1153-62. PubMed ID: 16751252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of rat I-TAC/CXCL11/SCYA11 during central nervous system inflammation: comparison with other CXCR3 ligands.
    McColl SR; Mahalingam S; Staykova M; Tylaska LA; Fisher KE; Strick CA; Gladue RP; Neote KS; Willenborg DO
    Lab Invest; 2004 Nov; 84(11):1418-29. PubMed ID: 15322564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of the genes for Cxcl9 and Cxcl10 is dependent on IFN-gamma but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia in vitro.
    Carter SL; Müller M; Manders PM; Campbell IL
    Glia; 2007 Dec; 55(16):1728-39. PubMed ID: 17902170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFN-gamma regulates murine interferon-inducible T cell alpha chemokine (I-TAC) expression in dendritic cell lines and during experimental autoimmune encephalomyelitis (EAE).
    Hamilton NH; Banyer JL; Hapel AJ; Mahalingam S; Ramsay AJ; Ramshaw IA; Thomson SA
    Scand J Immunol; 2002 Feb; 55(2):171-7. PubMed ID: 11896933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells.
    Chung CY; Liao F
    J Neuroinflammation; 2016 Apr; 13(1):76. PubMed ID: 27068264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The heat shock response reduces myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in mice.
    Heneka MT; Sharp A; Murphy P; Lyons JA; Dumitrescu L; Feinstein DL
    J Neurochem; 2001 Apr; 77(2):568-79. PubMed ID: 11299319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralization of IFN-inducible protein 10/CXCL10 exacerbates experimental autoimmune encephalomyelitis.
    Narumi S; Kaburaki T; Yoneyama H; Iwamura H; Kobayashi Y; Matsushima K
    Eur J Immunol; 2002 Jun; 32(6):1784-91. PubMed ID: 12115662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
    Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
    J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of experimental autoimmune encephalomyelitis: effect of altered peptide ligand on chemokine and chemokine receptor expression.
    Fischer FR; Santambrogio L; Luo Y; Berman MA; Hancock WW; Dorf ME
    J Neuroimmunol; 2000 Oct; 110(1-2):195-208. PubMed ID: 11024550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination.
    Gran B; Zhang GX; Yu S; Li J; Chen XH; Ventura ES; Kamoun M; Rostami A
    J Immunol; 2002 Dec; 169(12):7104-10. PubMed ID: 12471147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+IL-10+ T cells, CD4(-) IFN-gamma+ cells, and decreased macrophage IL-6 expression.
    Imler TJ; Petro TM
    Int Immunopharmacol; 2009 Jan; 9(1):134-43. PubMed ID: 19022403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chemokine receptor antagonist, TAK-779, decreased experimental autoimmune encephalomyelitis by reducing inflammatory cell migration into the central nervous system, without affecting T cell function.
    Ni J; Zhu YN; Zhong XG; Ding Y; Hou LF; Tong XK; Tang W; Ono S; Yang YF; Zuo JP
    Br J Pharmacol; 2009 Dec; 158(8):2046-56. PubMed ID: 20050195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines.
    Tran EH; Prince EN; Owens T
    J Immunol; 2000 Mar; 164(5):2759-68. PubMed ID: 10679118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR3 signaling reduces the severity of experimental autoimmune encephalomyelitis by controlling the parenchymal distribution of effector and regulatory T cells in the central nervous system.
    Müller M; Carter SL; Hofer MJ; Manders P; Getts DR; Getts MT; Dreykluft A; Lu B; Gerard C; King NJ; Campbell IL
    J Immunol; 2007 Sep; 179(5):2774-86. PubMed ID: 17709491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokine receptor CXCR3: an unexpected enigma.
    Liu L; Callahan MK; Huang D; Ransohoff RM
    Curr Top Dev Biol; 2005; 68():149-81. PubMed ID: 16124999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant immunotherapy of experimental autoimmune encephalomyelitis: immature myeloid cells expressing CXCL10 and CXCL16 attract CXCR3+CXCR6+ and myelin-specific T cells to the draining lymph nodes rather than the central nervous system.
    O'Connor RA; Li X; Blumerman S; Anderton SM; Noelle RJ; Dalton DK
    J Immunol; 2012 Mar; 188(5):2093-101. PubMed ID: 22287719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.